Spraying spray bottle
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward

Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?

Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?

mucosal vaccine
Mucosal Vaccines Protect Mice from Viruses, Cancer
Emma Yasinski | Jun 1, 2021
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Bacteria Boost Vaccine Effectiveness
Sabrina Richards | Feb 10, 2013
Researchers are looking to microbes to improve immune responses to a wide range of vaccines.